- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03464812
Evaluating Outcomes for Ethnically Diverse Patients With Type 2 Diabetes Participating in a Diabetes Education Program (DSMES)
Evaluating Patient Engagement and Other Outcomes for Ethnically Diverse Patients With Type 2 Diabetes Participating in a Structured, Physician Supported, Patient-centered Diabetes Education Program
Study Overview
Detailed Description
Diabetes is a chronic and a progressive metabolic disorder which necessitates active patient involvement to effectively manage nutrition, physical activity, and medication for optimal outcomes. Self-management is a critical aspect of diabetes care and a variety of studies have established the need for people with diabetes to be knowledgeable about their condition and be actively involved in its management to effectively reduce the risk of future health complications and improve other outcomes. Diabetes self-management education and support (DSMES) can help patients effectively engage in and perform their diabetes-related self-care activities. However, only a small number of patients with diabetes participate in DSMES. A few studies in this area have highlighted both physician and patient-related factors that could affect the receipt of DSMES. Patients' involvement in a DSMES program continues to be largely prompted by a physician referral and it has been suggested that improving physician involvement in the DSMES process could enhance overall patient engagement and adherence to such programs.
As part of the proposed mixed methods study, in Phase 1, in-depth surveys (or interviews) will be undertaken with: (a) physicians caring for people with type 2 diabetes, (b) DSMES providers (e.g., certified diabetes educators, diabetes nurses, dietitians), and (b) patients with type 2 diabetes regarding their perception of diabetes education programs, barriers, and facilitators to engagement. Findings from Phase 1 will be shared with the education team at a diabetes center in a community hospital in Orange County, California to inform changes to their currently existing diabetes education curriculum to make it more patient-centered and improve physician engagement and support. As part of Phase 2, the newly developed program will be implemented with a diverse cohort of 90 patients with type 2 diabetes. Patient participation (attendance) in the DSMES process will be documented as a primary marker of patient engagement while their clinical and psycho-social outcomes will serve as secondary indicators. Among other outcomes, physician, educator, and patient satisfaction with the newly developed referral process will also be assessed as a measure of intervention acceptability and success.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Newport Beach, California, United States, 92663
- Mary & Dick Allen Diabetes Center, Hoag Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients of White, Asian, or Hispanic origin (30 in each group) Fluent in English (for the White and Asian group) Fluent in Spanish (for the Hispanic group) Age > 18 years Physician referral for DSME/S Formal diagnosis of type 2 diabetes
Exclusion Criteria:
Current or planned pregnancy. Any medical or other condition that the investigator feels would interfere with study participation.
Mental incapacity precluding adequate understanding or cooperation. Potential participants who are imprisoned or hospitalized
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: DSMES Group
Patients with type 2 diabetes will undergo a diabetes education program (DSMES) and evaluated for outcomes before and after completing the program.
|
It is primarily an educational intervention that is focused on assisting patients improve their management and coping with type 2 diabetes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Program completion
Time Frame: Approximately at 4 months from the start of the study.
|
Evaluate the rate of program completion in study participants
|
Approximately at 4 months from the start of the study.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic control
Time Frame: At baseline and repeated after approximately 4 months
|
Evaluated using HbA1c (blood test)
|
At baseline and repeated after approximately 4 months
|
Diabetes-specific quality of life
Time Frame: At baseline and repeated after approximately 4 months
|
Measure assessing diabetes-specific quality of life
|
At baseline and repeated after approximately 4 months
|
Diabetes-related distress
Time Frame: At baseline and repeated after approximately 4 months
|
Measure assessing diabetes-related distress or problem areas in diabetes
|
At baseline and repeated after approximately 4 months
|
Diabetes self-care
Time Frame: At baseline and repeated after approximately 4 months
|
Measure assessing diabetes-related self-care
|
At baseline and repeated after approximately 4 months
|
Diabetes-related self efficacy
Time Frame: At baseline and repeated after approximately 4 months
|
Measure assessing diabetes-related self-efficacy
|
At baseline and repeated after approximately 4 months
|
Patient and referring provider satisfaction
Time Frame: Approximately at 4 months from the start of the study.
|
Measures to assess patient and referring provider related satisfaction with the program.
|
Approximately at 4 months from the start of the study.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Harsimran Harsimran, PhD, Hoag Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RADC2018_1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type2 Diabetes
-
Mathias Ried-LarsenUnknownDiabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus | Type2 Diabetes | Type2 Diabetes MellitusDenmark
-
Johns Hopkins UniversityBeth Israel Deaconess Medical CenterActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Diabetes | Diabetes type2 | Type 2 Diabetes | Type2 Diabetes | Type II Diabetes | High Blood PressureUnited States
-
Sigrid Therapeutics ABCompletedOverweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre DiabetesFinland, Sweden
-
University of ChicagoCompleted
-
Michigan State UniversityUniversity of Michigan; Claremont Graduate UniversityUnknown
-
University of AlbertaSherwood Park Strathcona County Primary Care Network, AlbertaCompleted
-
Region SkaneGöteborg UniversityActive, not recruitingType2 DiabetesSweden
-
University of Missouri-ColumbiaCompleted
-
University Hospital, Gentofte, CopenhagenCompletedType2 DiabetesDenmark
Clinical Trials on DSMES
-
Villanova UniversityRecruiting
-
Omada Health, Inc.Palo Alto Medical Foundation; Sutter HealthTerminatedType 2 DiabetesUnited States
-
MedsPLUS ConsultingNational Institutes of Health (NIH); Lister Hill Center for Health Policy; Jenkins...Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes
-
University of ArizonaRecruiting
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Not yet recruitingType 2 DiabetesUnited States
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruitingType 2 DiabetesUnited States
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedHypertension | Diabetes Mellitus | High Blood Pressure | High Blood SugarUnited States
-
Omada Health, Inc.Abbott Diabetes Care; Evidation HealthCompletedType 2 DiabetesUnited States
-
Sinai Health SystemRecruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Mellitus, Type 1United States
-
University of ArkansasWithdrawnDiabetes Mellitus, Type 2 | Sleep HygieneUnited States